Biotech startups that raised Series B in San Francisco, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Multiply Labs | San Francisco | Series B | $75.0M | 2026-10-06 |
| LTZ Therapeutics | San Francisco | Series B | $38.0M | 2026-05-06 |
| Aeovian Pharmaceuticals | San Francisco | Series B | $55.0M | 2025-12-16 |
| GALY | San Francisco | Series B | $33.0M | 2024-09-03 |
| Marea Therapeutics | San Francisco | Series B | $190.0M | 2024-06-18 |
| Attralus | San Francisco | Series B | $56.0M | 2024-02-06 |
| Septerna | San Francisco | Series B | $150.0M | 2023-07-11 |
| Incode Technologies | San Francisco | Series B | $220.0M | 2021-12-07 |
8 rows of the CSV in 5 of its 18 columns.
- The 34 biotech startups in San Francisco, United States whose last round is Series B have raised $2.8B in total.
- 6 of them closed their most recent round in the last 12 months, $500.0M combined.
- The largest of those rounds is Osanni Bio's $190.0M Series B, dated June 2026.
- The most recent is Multiply Labs' $75.0M Series B on 6 October 2026.
- Samsara BioCapital is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 27 companies (79%).
- 18% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (45% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 34| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Multiply Labs | Multiply Labs builds robotic systems that automate biologics manufacturing. | Artificial intelligence | Series B | $75.0M | 2026-10-06 | $97.7M | Y Combinator, Founders Fund, Garage Capital +2 | 11 to 50 | 2016 |
| LTZ Therapeutics | LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. | Biotech | Series B | $38.0M | 2026-05-06 | $125.0M | Qiming Venture Partners, Shunwei Capital, K2VC +1 | 11 to 50 | 2022 |
| Aeovian Pharmaceuticals | Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. | Biotech | Series B | $55.0M | 2025-12-16 | $142.0M | Sofinnova Investments, venBio Partners, Apollo Health Ventures | 1 to 10 | 2012 |
| Incode Technologies Unicorn | Incode Technologies provides omnichannel biometric identity verification for real-life identity checks. | Biotech | Series B | $220.0M | 2021-12-07 | $257.1M | FJ Labs, SoftBank, Framework Ventures +2 | 501 to 1,000 | 2015 |
| Qualio | Qualio provides a quality management system for life sciences companies. | Biotech | Series B | $50.0M | 2021-05-25 | $66.1M | 500 Global, Tiger Global Management, Menlo Ventures +2 | 51 to 100 | 2012 |
Table 1. Biotech startups that raised Series B in San Francisco, United States: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 34.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Multiply Labs | Multiply Labs builds robotic systems that automate biologics manufacturing. | Artificial intelligence | Series B | $75.0M | 2026-10-06 | $97.7M | Y Combinator, Founders Fund, Garage Capital +2 | 11 to 50 | 2016 |
| 2 | Aeovian Pharmaceuticals | Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. | Biotech | Series B | $55.0M | 2025-12-16 | $142.0M | Sofinnova Investments, venBio Partners, Apollo Health Ventures | 1 to 10 | 2012 |
| 3 | LTZ Therapeutics | LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. | Biotech | Series B | $38.0M | 2026-05-06 | $125.0M | Qiming Venture Partners, Shunwei Capital, K2VC +1 | 11 to 50 | 2022 |
Table 2. Biotech startups that raised Series B in San Francisco, United States: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Samsara BioCapital | Private equity firm | Palo Alto, United States | 2 | 6% | ||
| 2 | Y Combinator | Startup accelerator | Mountain View, United States | 1 | 3% | 1 | Multiply Labs |
| 3 | Casdin Capital | Venture capital firm | New York, United States | 1 | 3% | 1 | Multiply Labs |
| 4 | Garage Capital | Venture capital firm | Waterloo, Canada | 1 | 3% | 1 | Multiply Labs |
| 5 | Fifty Years | Micro VC fund | San Francisco, United States | 1 | 3% | 1 | Multiply Labs |
| 6 | Founders Fund | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Multiply Labs |
| 7 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 1 | 3% | 1 | LTZ Therapeutics |
| 8 | K2VC | Angel group | Beijing, China | 1 | 3% | 1 | LTZ Therapeutics |
| 9 | Lapam Capital | Venture capital firm | Beijing, China | 1 | 3% | 1 | LTZ Therapeutics |
| 10 | Shunwei Capital | Venture capital firm | Beijing, China | 1 | 3% | 1 | LTZ Therapeutics |
| 11 | venBio Partners | Venture capital firm | San Francisco, United States | 1 | 3% | 1 | Aeovian Pharmaceuticals |
| 12 | Apollo Health Ventures | Startup incubator | Hamburg, Germany | 1 | 3% | 1 | Aeovian Pharmaceuticals |
| 13 | Sofinnova Investments | Venture capital firm | Menlo Park, United States | 1 | 3% | 1 | Aeovian Pharmaceuticals |
| 14 | Lake House | Private equity firm | Hong Kong | 1 | 3% | ||
| 15 | Artesian VC | Venture capital firm | Melbourne, Australia | 1 | 3% |
Table 3. Biotech startups that raised Series B in San Francisco, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 27 | 79% | $2.1B |
| Software | 8 | 24% | $826.4M |
| Artificial intelligence | 3 | 9% | $237.2M |
| Fintech | 2 | 6% | $282.7M |
| Cybersecurity | 2 | 6% | $282.7M |
| Hardware | 1 | 3% | $97.7M |
| Commerce | 1 | 3% | $74.4M |
| Energy | 1 | 3% | $74.4M |
Table 4. Biotech startups that raised Series B in San Francisco, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 34 | 100% | $40.0M |
Table 5. Biotech startups that raised Series B in San Francisco, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 17% | $75.0M |
| August 2026 | 1 | 17% | $115.0M |
| June 2026 | 1 | 17% | $190.0M |
| May 2026 | 1 | 17% | $38.0M |
| April 2026 | 1 | 17% | $27.0M |
| December 2025 | 1 | 17% | $55.0M |
Table 6. Biotech startups that raised Series B in San Francisco, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 5 | 15% | $445.0M |
| 2025 | 1 | 3% | $55.0M |
| 2024 | 3 | 9% | $279.0M |
| 2023 | 3 | 9% | $190.0M |
| 2022 | 4 | 12% | $165.3M |
| 2021 | 5 | 15% | $366.0M |
Table 7. Biotech startups that raised Series B in San Francisco, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 3% |
| 2020 to 2022 | 5 | 15% |
| 2015 to 2019 | 11 | 32% |
| 2010 to 2014 | 9 | 26% |
| Before 2010 | 8 | 24% |
Table 8. Biotech startups that raised Series B in San Francisco, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 7 | 21% |
| 11 to 50 | 15 | 45% |
| 51 to 100 | 8 | 24% |
| 101 to 250 | 2 | 6% |
| 501 to 1,000 | 1 | 3% |
Table 9. Biotech startups that raised Series B in San Francisco, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in San Francisco, United States. On 16 November 2026 that is 34 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 34 rows: 2 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in San Francisco, United States whose last round is Series B are on the list?
- 34, in the file dated 16 November 2026. 6 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.